R Andrew Seaton Selected Research

R Andrew Seaton Research Topics

19	Infections 04/2022 - 02/2003
8	Endocarditis 05/2016 - 04/2011
5	Soft Tissue Infections 01/2016 - 01/2011
3	COVID-19 10/2022 - 06/2021
2	Surgical Wound Infection 06/2021 - 09/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 06/2021 - 06/2021
2	Hypersensitivity (Allergy) 03/2021 - 01/2021
2	Death (Near-Death Experience) 01/2021 - 11/2020
2	Osteomyelitis 07/2013 - 04/2011
1	Virus Diseases (Viral Diseases) 06/2021
1	Coinfection 06/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2016
1	Diabetes Mellitus 03/2016
1	Cross Infection (Nosocomial Infection) 01/2016
1	Foreign Bodies (Foreign Body) 12/2015
1	Bacteremia 12/2015
1	Drug-Related Side Effects and Adverse Reactions 07/2013
1	Renal Insufficiency (Renal Failure) 07/2013
1	Staphylococcal Infections 04/2013
1	Streptococcal Infections (Streptococcal Infection) 06/2012
1	Acute Kidney Injury (Acute Renal Failure) 08/2011
1	Cellulitis 05/2005

16	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 05/2005
9	Daptomycin FDA Link 05/2016 - 01/2011
2	CoagulaseIBA 12/2015 - 07/2013
2	Methicillin (Metin)FDA Link 05/2013 - 04/2013
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2012 - 05/2005
1	VaccinesIBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Penicillins (Penicillin)FDA Link 03/2021
1	Vancomycin FDA LinkGeneric 05/2016
1	LipopeptidesIBA 01/2016
1	TeicoplaninIBA 07/2013
1	Gentamicins (Gentamicin)FDA LinkGeneric 08/2011
1	abacavir, lamivudine, and zidovudine drug combination FDA Link 02/2003
1	Zidovudine (Retrovir)FDA LinkGeneric 02/2003
1	Lamivudine (Epivir)FDA Link 02/2003
1	abacavir (Ziagen)FDA Link 02/2003

7	Therapeutics 06/2021 - 05/2005
1	Drug Therapy (Chemotherapy) 04/2022
1	Ambulatory Care (Outpatient Care) 06/2021
1	Inappropriate Prescribing 06/2021
1	Critical Care (Surgical Intensive Care) 06/2021
1	Antibiotic Prophylaxis 09/2020
1	Duration of Therapy 01/2019
1	Patient Readmission 07/2013
1	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2011